The Nucleic Acids Chemistry group, led by Prof. Ramon Eritja’s of the IQAC (CSIC), is participating in a multidisciplinary network for Myotonic Dystrophy Type 1 (DM1) with other 6 research groups...
Read more
In this context, the doctoral thesis of the Lorena Joga, child and youth neuropsychologist at Parc Taulí and member of the I3PT Growth and Developmental Disorders Research Group, with the title "Frag...
Read more
Researchers have joined forces to design using artificial intelligence and produce next-generation viral particles to be applied in advanced therapies. These particles can be used in immunotherapies, ...
Read more
A research team from the Institut de Recerca Sant Joan de Déu · SJD Barcelona Children’s Hospital is participating in an international clinical trial of a gene therapy for Duchenne muscular dystro...
Read more
CNIO researchers provide a new hypothesis to understand the origin of amyotrophic lateral sclerosis, or ALS. It would be triggered by a similar problem to that occurring in a group of rare diseases ca...
Read more
La FDA ha aprobado Duvyzat (givinostat), un medicamento oral, para el tratamiento de la Distrofia Muscular de Duchenne (DMD) en pacientes de 6 años o más.
Read more
SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary Artificial Intelligence platform (SOMAIPRO®), is pleased to announce that the recruitment of the Pha...
Read more
The study demonstrates that a specific genetic mutation (C122Y) in the Kir2.1 potassium channel alters the function not only of Kir2.1 but also of the main cardiac sodium channel NaV1.5, thus establis...
Read more
Las innovadoras técnicas de modelos de enfermedades y edición de genes empiezan a dar respuesta a cuestiones pendientes desde hace tiempo.
Read more
A paper published in the journal Cells has identified a potential modifier gene for PCD by studying a family in which the mother and two sons are affected by X-linked retinitis pigmentosa (XLRP), and ...
Read more
Vall d'Hebron presents positive results from two studies in transfusion-dependent thalassaemia and severe bone marrow aplasia at the EBMT Annual Meeting on haematopoietic stem cell transplantation.
Read more
Research led by IIBB-CSIC and CIBEREHD scientists identifies S-adenosyl-L-methionine (SAM) as a new therapeutic strategy for this hereditary disease that causes neurodegeneration.
Read more
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
La revista ‘Nature Protocols’ selecciona esta técnica como “pro...
